Global Financial Private Capital’s Pfizer PFE Stock Holding History

Global Financial Private Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$10.5M	Sell	338,756 -45,130	-12%	-$1.53M	0.66%	48
2020 Q1	$11.9M	Buy	383,886 +64,310	+20%	+$2.19M	0.75%	43
2019 Q4	$11.9M	Buy	319,576 +121,793	+62%	+$4.34M	0.6%	48
2019 Q3	$6.74M	Buy	197,783 +109,026	+123%	+$3.96M	0.34%	84
2019 Q2	$3.65M	Sell	88,757 -11,159	-11%	-$443K	0.18%	128
2019 Q1	$4.03M	Sell	99,916 -16,608	-14%	-$665K	0.19%	116
2018 Q4	$4.83M	Sell	116,524 -235,446	-67%	-$9.77M	0.26%	94
2018 Q3	$14.7M	Buy	351,970 +12,542	+4%	+$483K	0.53%	52
2018 Q2	$11.7M	Buy	339,428 +182,905	+117%	+$6.25M	0.4%	70
2018 Q1	$5.27M	Sell	156,523 -23,315	-13%	-$802K	0.18%	106
2017 Q4	$6.18M	Buy	179,838 +53,597	+42%	+$1.83M	0.21%	88
2017 Q3	$4.28M	Buy	126,241 +75,816	+150%	+$2.44M	0.15%	101
2017 Q2	$1.61M	Buy	50,425 +10,097	+25%	+$318K	0.08%	134
2017 Q1	$1.31M	Buy	+40,328	New	+$1.27M	0.07%	146

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Global Financial Private Capital's PFE Position: Q2 2020 in Review

Global Financial Private Capital reduced its Pfizer (PFE) stake by 12% in Q2 2020, selling an estimated $1.53M and leaving 338,756 shares worth $10.5M. The position accounts for 0.66% of the portfolio, ranked #48.

Global Financial Private Capital first reported a position in PFE in Q1 2017 and has held it in 14 quarters since. The position peaked at $14.7M in Q3 2018. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

Global Financial Private Capital held 338,756 shares of Pfizer worth $10.5M as of Q2 2020.
Global Financial Private Capital sold 45,130 Pfizer shares in Q2 2020, an estimated $1.53M.
Pfizer made up 0.66% of Global Financial Private Capital's portfolio in Q2 2020, its #48 holding.
Global Financial Private Capital first reported a position in Pfizer in Q1 2017 and has held it in 14 quarters since.
Global Financial Private Capital's Pfizer position peaked at $14.7M in Q3 2018.
2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.